Pan C F, Wu C J, Chen H H, Dang C W, Chang F M, Liu H F, Chu C C, Lin M, Lee Y J
Departments of Nephrology, Mackay Memorial Hospital, Taipei; Departments of Mackay Medicine, Nursing and Management College, Taipei, Taiwan.
Lupus. 2009 Jul;18(8):698-704. doi: 10.1177/0961203308101955.
To evaluate the association of human leukocyte antigen (HLA)-DRB1 alleles with systemic lupus erythematosus (SLE) and lupus nephritis (LN) in the Taiwanese population, and to investigate the possible association of HLA-DRB1 alleles with disease severity in LN. HLA-DRB1 alleles were studied in 105 SLE patients (82 patients with LN, 23 patients without LN) and 855 healthy controls by polymerase chain reaction and sequence-based typing assays. The frequency of the HLA class II alleles DRB10301 (Odds ratio [OR] = 2.01, 95% confidence interval [CI] = 1.31-3.10, Pc = 0.02) and DRB11501 (OR = 2.06, 95% CI = 1.36-3.13, Pc = 0.01) were both increased in SLE patients, compared to healthy controls. The frequency of DRB11202 was significantly lower in LN patients than in SLE patients without nephritis (OR = 0.23, 95% CI = 0.09-0.57, Pc = 0.01). No specific allele was significantly associated with an increased or decreased risk for severity of LN in this sample. In Taiwanese people, the DRB10301 and DRB11501 alleles are significant risk factors for SLE, while the DRB11202 allele is protective for LN.
为评估台湾人群中人类白细胞抗原(HLA)-DRB1等位基因与系统性红斑狼疮(SLE)及狼疮性肾炎(LN)的关联,并研究HLA-DRB1等位基因与LN疾病严重程度的可能关联。通过聚合酶链反应和基于序列的分型检测,对105例SLE患者(82例LN患者,23例无LN患者)和855例健康对照者的HLA-DRB1等位基因进行了研究。与健康对照相比,SLE患者中HLA II类等位基因DRB10301(优势比[OR]=2.01,95%置信区间[CI]=1.31 - 3.10,Pc = 0.02)和DRB11501(OR = 2.06,95% CI = 1.36 - 3.13,Pc = 0.01)的频率均升高。LN患者中DRB11202的频率显著低于无肾炎的SLE患者(OR = 0.23,95% CI = 0.09 - 0.57,Pc = 0.01)。在该样本中,没有特定等位基因与LN严重程度的风险增加或降低显著相关。在台湾人群中,DRB10301和DRB11501等位基因是SLE的重要危险因素,而DRB11202等位基因对LN具有保护作用。